peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

pancreatic peptide bioregulator

Pancragen

Published evidence · coverage incomplete

Anatomy in the research

Anatomy evidence is still being assembled.

These are anatomical mentions in cited research—not established treatment targets or proof of benefit in people.

This publication has no anatomy passages that meet our source-linking checks yet. Read the available findings ↓

General anatomy view only. No peptide-specific structures are highlighted.

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

Pancragen is described as a tetrapeptide (a peptide made of four amino acids).

Sources[2]pubmed[Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys].The aim of the investigation was comparative study of the influence tetrapeptide Pancragen
Molecular / pharmacology evidence

1 cited source · Study independence not established

How to read this evidence

Sources and study IDs describe provenance, not clinical strength. Several articles can report the same study; one study can support several distinct findings. No clinical strength rating has been assigned here.

1 cited passage across 1 source record. 1 publication group(s) lack a resolved study identity.

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “The aim of the investigation was comparative study of the influence tetrapeptide Pancragen”

    [Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys]. · Abstract

    pubmed:28509500:19f92b822017:19f92b822017

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Additional research & classification gaps

2 archived statements are kept separate from drug-effect findings. Media studies, economic models, methods, and records with unresolved scope are not used as medical-effect evidence.

Inspect contextual research (2)
Research context · scope unclassified

1 cited source · Study independence not established

How to read this evidence

Sources and study IDs describe provenance, not clinical strength. Several articles can report the same study; one study can support several distinct findings. No clinical strength rating has been assigned here.

1 cited passage across 1 source record. 1 publication group(s) lack a resolved study identity.

In aged rhesus monkeys, administration of either Pancragen or glimepiride was associated with decreased basal blood glucose levels.

Research context only—not evidence of a treatment effect.

Research context · scope unclassified

1 cited source · Study independence not established

How to read this evidence

Sources and study IDs describe provenance, not clinical strength. Several articles can report the same study; one study can support several distinct findings. No clinical strength rating has been assigned here.

1 cited passage across 1 source record. 1 publication group(s) lack a resolved study identity.

Pancragen is defined here as a tetrapeptide composed of Lys-Glu-Asp-Trp.

Research context only—not evidence of a treatment effect.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, interaction, mechanism, regulatory, safety
  • 17 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (12), assurance_score_below_0.72 (2), current_regulatory_source_required (2), extraction_ambiguity (14), high_risk_requires_regulatory_or_two_independent_sources (5), no_direct_support (14)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. [Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys]. ↗

    pubmed · published 2014-01-01 · retrieved 2026-09-09T18:03:15Z

  2. [Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys]. ↗

    pubmed · published 2015-01-01 · retrieved 2026-09-09T18:03:15Z

Publication history and provenance

Version 2 · Automated assessment · 2026-09-09T18:03:15Z

ea83d2d7ec9f119afaa12a94ba2783b1d48b5daab696cc39a6c2b60de2bd7be4